within Pharmacolibrary.Drugs.V_Various.V04C_OtherDiagnosticAgents.V04CG02_Betazole;

model Betazole
  extends Pharmacolibrary.Drugs.ATC.V.V04CG02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V04CG02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Betazole is a histamine H2 receptor agonist used diagnostically to stimulate gastric acid secretion, most notably in the diagnosis of gastric acid secretory capacity and in the diagnosis of Zollinger-Ellison syndrome. It is primarily of historical interest and is not widely used or approved in current clinical practice.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies with quantified parameters are available for betazole in humans, in any population.</p><h4>References</h4><ol><li><p>Bernhoft, A, et al., &amp; Grotmol, T (2001). Placental transfer of the estrogenic mycotoxin zearalenone in rats. <i>Reproductive toxicology (Elmsford, N.Y.)</i> 15(5) 545–550. DOI:<a href=\"https://doi.org/10.1016/s0890-6238(01)00159-9\">10.1016/s0890-6238(01)00159-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11780962/\">https://pubmed.ncbi.nlm.nih.gov/11780962</a></p></li><li><p>Dong, M, et al., &amp; Kumagai, S (2010). The toxic effects and fate of intravenously administered zearalenone in goats. <i>Toxicon : official journal of the International Society on Toxinology</i> 55(2-3) 523–530. DOI:<a href=\"https://doi.org/10.1016/j.toxicon.2009.10.004\">10.1016/j.toxicon.2009.10.004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19825386/\">https://pubmed.ncbi.nlm.nih.gov/19825386</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Betazole;
